相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity
Takehisa Kitazawa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study
Sayumi Yamazoe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Rati Verma et al.
MOLECULAR CELL (2020)
Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer
Matthew G. Costales et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Taking a BiTE out of ALL: blinatumomab approval for MRD-positive ALL
Emily Curran et al.
BLOOD (2019)
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
Shivani Srivastava et al.
CANCER CELL (2019)
Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
Juanjuan Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
Dario Neri
CANCER IMMUNOLOGY RESEARCH (2019)
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
Jana de Sostoa et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Gaurav Nayyar et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting Nuclear Receptors with PROTAC degraders
John J. Flanagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility
Jane Guan et al.
CELL (2019)
De novo design of bioactive protein switches
Robert A. Langan et al.
NATURE (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors
Ashwini Balakrishnan et al.
CLINICAL CANCER RESEARCH (2019)
Targeting cardiac fibrosis with engineered T cells
Haig Aghajanian et al.
NATURE (2019)
Chronic inflammation in multiple sclerosis - seeing what was always there
Paul M. Matthews
NATURE REVIEWS NEUROLOGY (2019)
CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity
Ji Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins
Ziyang Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Bifunctional chemical probes inducing protein-protein interactions
Chiara Maniaci et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
Meghdad Abdollahpour-Alitappeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Treating Disease at the RNA Level with Oligonucleotides
Arthur A. Levin
NEW ENGLAND JOURNAL OF MEDICINE (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
Re-Engineering RNA Molecules into Therapeutic Agents
Martin Egli et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Design and Production of Bispecific Antibodies
Qiong Wang et al.
ANTIBODIES (2019)
Bispecific antibodies in haematological malignancies
Andreas Viardot et al.
CANCER TREATMENT REVIEWS (2018)
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
Johannes Brozy et al.
JOURNAL OF VIROLOGY (2018)
Advanced siRNA Designs Further Improve In Vivo Performance of GaINAc-siRNA Conjugates
Donald J. Foster et al.
MOLECULAR THERAPY (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Chemically induced proximity in biology and medicine
Benjamin Z. Stanton et al.
SCIENCE (2018)
Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-immunoglobulin Scaffold Proteins
Johannes Winkler
NUCLEIC ACID THERAPEUTICS (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE (R)) antibody construct, in patients with refractory solid tumors
Maxim Kebenko et al.
ONCOIMMUNOLOGY (2018)
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
Jane Harper et al.
PLOS ONE (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Taisuke Uehara et al.
NATURE CHEMICAL BIOLOGY (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Targeting blood-brain-barrier transcytosis - perspectives for drug delivery
Imre Mager et al.
NEUROPHARMACOLOGY (2017)
Antibody therapies in CNS diseases
Per-Ola Freskgard et al.
NEUROPHARMACOLOGY (2017)
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
Haleh Saber et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Ting Han et al.
SCIENCE (2017)
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
BIODRUGS (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
Amita Datta-Mannan et al.
MABS (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Darren J. Baker et al.
NATURE (2016)
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y. Joy Yu Zuchero et al.
NEURON (2016)
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Christoph T. Ellebrecht et al.
SCIENCE (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Jason M. Lajoie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3
Morten Mau-Sorensen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
James Palacino et al.
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Combinatorial Approaches for the Identification of Brain Drug Delivery Targets
Charles C. Stutz et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Endogenous Nitrated Nucleotide Is a Key Mediator of Autophagy and Innate Defense against Bacteria
Chiaki Ito et al.
MOLECULAR CELL (2013)
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
Yuan Xiao Zhu et al.
LEUKEMIA & LYMPHOMA (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei et al.
PLOS ONE (2013)
Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo
Tomoyuki Igawa et al.
PLOS ONE (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1a
Dennis L. Buckley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Max S. Topp et al.
BLOOD (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
Structural Basis for the Blockage of IL-2 Signaling by Therapeutic Antibody Basiliximab
Jiamu Du et al.
JOURNAL OF IMMUNOLOGY (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
CAT-8015: A Second-Generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies
Ralph F. Alderson et al.
CLINICAL CANCER RESEARCH (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
The anchor-away technique: Rapid, conditional establishment of yeast mutant phenotypes
Hirohito Haruki et al.
MOLECULAR CELL (2008)
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
Ralf Bargou et al.
SCIENCE (2008)
Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial
Herbert Riechelmann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Xu Tan et al.
NATURE (2007)
Chemical genetic control of protein levels: Selective in vivo targeted degradation
JS Schneekloth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity
M Cortés et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Crystal structure of ARF1 center dot Sec7 complexed with brefeldin A and its implications for the guanine nucleotide exchange mechanism
E Mossessova et al.
MOLECULAR CELL (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Auxin regulates SCFTIR1-dependent degradation of AUX/IAA proteins
WM Gray et al.
NATURE (2001)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes
A Löffler et al.
BLOOD (2000)
Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate
ID Bernstein
LEUKEMIA (2000)
分享论文
